Literature DB >> 22372745

Prostate cancer chemoprevention by soy isoflavones: role of intestinal bacteria as the "second human genome".

Hideyuki Akaza1.   

Abstract

It has been found that the composition of intestinal microbiota can indicate the risk of disease to each individual. The concepts of biodynamics as used by the Benziger Winery in California, which treats every part of an agricultural environment as a living, breathing entity, can be usefully used in the construction of a system for cancer prevention, which seeks to use the relationship of coexistence (symbiosis) shared between people and intestinal symbiosis, that is, microbiota. Changes in the incidence rate of cancer among Japanese emigrants to Hawaii demonstrate the effect of the changes in the living environment. This leads to the hypothesis that an intake of soy-derived food products and the metabolization of the isoflavones they contain by intestinal microbiota is one of the factors for the significant difference in the incidence rate of prostate cancer among Asian and European/North American populations. It is further hypothesized that isoflavones, particularly equol, are a key factor in the difference in incidence rate between Asia and the West. It is suggested that not having equol converting bacteria in the intestine (non-equol producers) can be a risk factor for prostate cancer and that one direction for future research will be to examine the possibility of improving the intestinal environment to enable equol production.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22372745      PMCID: PMC7685082          DOI: 10.1111/j.1349-7006.2012.02257.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  24 in total

1.  Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men.

Authors:  Kotaro Ozasa; Masahiro Nakao; Yoshiyuki Watanabe; Kyohei Hayashi; Tsuneharu Miki; Kazuya Mikami; Mitsuru Mori; Fumio Sakauchi; Masakazu Washio; Yoshinori Ito; Koji Suzuki; Kenji Wakai; Akiko Tamakoshi
Journal:  Cancer Sci       Date:  2004-01       Impact factor: 6.716

2.  Special issue: The Human Intestinal Microbiota.

Authors:  Harry J Flint; Paul W O'Toole; Alan W Walker
Journal:  Microbiology       Date:  2010-11       Impact factor: 2.777

3.  Meta-analysis of soy food and risk of prostate cancer in men.

Authors:  Lin Yan; Edward L Spitznagel
Journal:  Int J Cancer       Date:  2005-11-20       Impact factor: 7.396

4.  Effect of dutasteride on the risk of prostate cancer.

Authors:  Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

5.  Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen.

Authors:  Naoto Miyanaga; Hideyuki Akaza; Shiro Hinotsu; Tomoaki Fujioka; Seiji Naito; Mikio Namiki; Satoru Takahashi; Yoshihiko Hirao; Shigeo Horie; Taiji Tsukamoto; Mitsuru Mori; Hirokazu Tsuji
Journal:  Cancer Sci       Date:  2011-11-09       Impact factor: 6.716

6.  Isolation of catechin-converting human intestinal bacteria.

Authors:  M Kutschera; W Engst; M Blaut; A Braune
Journal:  J Appl Microbiol       Date:  2011-05-04       Impact factor: 3.772

7.  Equol is a novel anti-androgen that inhibits prostate growth and hormone feedback.

Authors:  Trent D Lund; Daniel J Munson; Megan E Haldy; Kenneth D R Setchell; Edwin D Lephart; Robert J Handa
Journal:  Biol Reprod       Date:  2003-12-17       Impact factor: 4.285

8.  Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis.

Authors:  Lin Yan; Edward L Spitznagel
Journal:  Am J Clin Nutr       Date:  2009-02-11       Impact factor: 7.045

9.  Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center.

Authors:  Norie Kurahashi; Motoki Iwasaki; Manami Inoue; Shizuka Sasazuki; Shoichiro Tsugane
Journal:  J Clin Oncol       Date:  2008-11-17       Impact factor: 44.544

10.  Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men.

Authors:  K Fujimoto; M Tanaka; Y Hirao; Y Nagata; M Mori; N Miyanaga; H Akaza; W-J Kim
Journal:  Prostate Cancer Prostatic Dis       Date:  2008-01-08       Impact factor: 5.554

View more
  24 in total

Review 1.  Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Authors:  Solmaz Ohadian Moghadam; Seyed Ali Momeni
Journal:  Front Med       Date:  2020-06-30       Impact factor: 4.592

Review 2.  Prostate cancer trends in Asia.

Authors:  Hideyuki Akaza; Mizuki Onozawa; Shiro Hinotsu
Journal:  World J Urol       Date:  2016-09-19       Impact factor: 4.226

3.  S-EQUOL: a neuroprotective therapeutic for chronic neurocognitive impairments in pediatric HIV.

Authors:  Kristen A McLaurin; Hailong Li; Anna K Cook; Rosemarie M Booze; Charles F Mactutus
Journal:  J Neurovirol       Date:  2020-09-01       Impact factor: 2.643

4.  MLK3 is a direct target of biochanin A, which plays a role in solar UV-induced COX-2 expression in human keratinocytes.

Authors:  Tae-Gyu Lim; Jong-Eun Kim; Sung Keun Jung; Yan Li; Ann M Bode; Jun-Seong Park; Myeong Hun Yeom; Zigang Dong; Ki Won Lee
Journal:  Biochem Pharmacol       Date:  2013-08-12       Impact factor: 5.858

5.  Prostate-Specific Antigen Modulatory Effect of a Fermented Soy Supplement for Patients with an Elevated Risk of Prostate Cancer: a Non-Randomized, Retrospective Observational Registration.

Authors:  Antonino Battaglia; Gaëtan Devos; Guy Boeckx; Lieven Goeman; Lorenzo Tosco; Gert de Meerleer; Steven Joniau
Journal:  Curr Urol       Date:  2020-10-13

Review 6.  The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease.

Authors:  Reena Kumari; Senthilnathan Palaniyandi; Gerhard Carl Hildebrandt
Journal:  Bone Marrow Transplant       Date:  2021-05-29       Impact factor: 5.174

Review 7.  Impacts of gut bacteria on human health and diseases.

Authors:  Yu-Jie Zhang; Sha Li; Ren-You Gan; Tong Zhou; Dong-Ping Xu; Hua-Bin Li
Journal:  Int J Mol Sci       Date:  2015-04-02       Impact factor: 5.923

8.  Phytoestrogens and risk of prostate cancer: a meta-analysis of observational studies.

Authors:  Jinjing He; Shuai Wang; Mi Zhou; Weiwen Yu; Yuelong Zhang; Xiang He
Journal:  World J Surg Oncol       Date:  2015-07-31       Impact factor: 2.754

Review 9.  Probiotics as efficient immunopotentiators: translational role in cancer prevention.

Authors:  Kan Shida; Koji Nomoto
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

10.  Potential role of gastrointestinal microbiota composition in prostate cancer risk.

Authors:  E Susan Amirian; Joseph F Petrosino; Nadim J Ajami; Yanhong Liu; Martha P Mims; Michael E Scheurer
Journal:  Infect Agent Cancer       Date:  2013-11-04       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.